Migraine in the triptan era: progresses achieved, lessons learned and future developments

Arquivos de Neuro-Psiquiatria

Marcelo E. Bigal²  Abouch V. Krymchantowski¹  Tony Ho¹ 

[1] ,Albert Einstein College of Medicine Department of Neurology Bronx NY ,U.S.

关键词: migraine;    triptans;    CGRP antagonists;    emerging drugs;    migrânea;    enxaqueca;    triptanos;    antagonistas do CGRP;   

DOI  :  10.1590/S0004-282X2009000300040

来源: SciELO

【 摘 要 】

Triptans, serotonin 5-HT1B/1D receptor agonists, more than revolutionizing the treatment of migraine, stimulated also ground breaking research that provided insights into the anatomy, physiology, and molecular pharmacology of migraine. This knowledge, in turn, is stimulating research on new mechanisms of action for the treatment of migraine. Accordingly, it is opportune to critically review the main advances in migraine science that happened in the triptan era. Herein we first review and conceptualize some of the progresses achieved in migraine science during the triptan era. We then review the class of the triptans - mechanism of action and clinical evidence. We close by briefly discussing the class of CGRP receptor antagonists, which is currently being developed for the acute treatment of migraine.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License